Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225 SEK | +2.93% | -7.41% | -15.98% |
Jun. 10 | Global markets live: ABB, Roche, Microsoft, Apple, Tesla... | |
Jun. 10 | BioArctic Reports US FDA's Acceptance of Biologics License Application for Leqembi IV Maintenance Dosing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.98% | 1.84B | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- BIOA B Stock
- News BioArctic AB
- BioArctic, Eisai Launch Rolling US FDA Application for Leqembi's Maintenance Dosing